To determine the possible mechanisms of decreased transformed phenotype, and migration inhibition in gastric cancer cell lines by Mel-18 overexpression or knockdown of BMI1 expression, we examined the expression of p16 and phosphorylated AKT in control and Mel-18 overexpressing or BMI1 knockdown cells. The gene discussed is CDKN2A; the disease is gastric cancer.